Vita Life Sciences Limited (VLS.AX)
AUD 1.7
(-3.95%)
AUD 1.7
(-3.95%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 42.6 Million AUD | 7.21% |
| 2022 | 39.74 Million AUD | 14.17% |
| 2021 | 34.8 Million AUD | 18.91% |
| 2020 | 29.27 Million AUD | 4.93% |
| 2019 | 27.89 Million AUD | 0.93% |
| 2018 | 27.64 Million AUD | 7.91% |
| 2017 | 25.61 Million AUD | -2.07% |
| 2016 | 26.15 Million AUD | -3.67% |
| 2015 | 27.15 Million AUD | 4.27% |
| 2014 | 26.04 Million AUD | 8.31% |
| 2013 | 24.04 Million AUD | 23.2% |
| 2012 | 19.51 Million AUD | 24.17% |
| 2011 | 15.71 Million AUD | 27.45% |
| 2010 | 12.33 Million AUD | 20.15% |
| 2009 | 10.26 Million AUD | 19.57% |
| 2008 | 8.58 Million AUD | 26.04% |
| 2007 | 6.81 Million AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 22.98 Million AUD | 0.0% |
| 2023 Q2 | 19.68 Million AUD | 0.0% |
| 2023 Q4 | 22.92 Million AUD | 0.0% |
| 2023 FY | 42.6 Million AUD | 7.21% |
| 2022 Q2 | 18.97 Million AUD | 0.0% |
| 2022 Q4 | 20.15 Million AUD | 0.0% |
| 2022 FY | 39.74 Million AUD | 14.17% |
| 2021 Q4 | 18.7 Million AUD | 0.0% |
| 2021 FY | 34.8 Million AUD | 18.91% |
| 2021 Q2 | 15.69 Million AUD | 0.0% |
| 2020 Q2 | 13.84 Million AUD | 0.0% |
| 2020 Q4 | 14.87 Million AUD | 0.0% |
| 2020 FY | 29.27 Million AUD | 4.93% |
| 2019 FY | 27.89 Million AUD | 0.93% |
| 2019 Q4 | 14.07 Million AUD | 0.0% |
| 2019 Q2 | 13.21 Million AUD | 0.0% |
| 2018 Q2 | 13.42 Million AUD | 94.29% |
| 2018 Q1 | 6.91 Million AUD | -46.95% |
| 2018 Q4 | 14.21 Million AUD | 0.0% |
| 2018 FY | 27.64 Million AUD | 7.91% |
| 2017 Q4 | 13.02 Million AUD | 0.0% |
| 2017 Q1 | 6.4 Million AUD | -52.9% |
| 2017 FY | 25.61 Million AUD | -2.07% |
| 2017 Q2 | 12.05 Million AUD | 88.26% |
| 2016 Q2 | 12.56 Million AUD | 92.09% |
| 2016 Q1 | 6.53 Million AUD | -54.43% |
| 2016 FY | 26.15 Million AUD | -3.67% |
| 2016 Q4 | 13.59 Million AUD | 0.0% |
| 2015 Q4 | 14.35 Million AUD | 111.42% |
| 2015 FY | 27.15 Million AUD | 4.27% |
| 2015 Q2 | 12.8 Million AUD | 88.58% |
| 2015 Q1 | 6.78 Million AUD | -49.14% |
| 2015 Q3 | 6.78 Million AUD | -46.97% |
| 2014 Q3 | 6.51 Million AUD | -48.72% |
| 2014 Q2 | 12.69 Million AUD | 94.99% |
| 2014 Q1 | 6.51 Million AUD | -48.26% |
| 2014 FY | 26.04 Million AUD | 8.31% |
| 2014 Q4 | 13.34 Million AUD | 105.01% |
| 2013 Q1 | 6.01 Million AUD | 0.0% |
| 2013 Q4 | 12.58 Million AUD | 109.32% |
| 2013 Q3 | 6.01 Million AUD | -47.55% |
| 2013 Q2 | 11.46 Million AUD | 90.68% |
| 2013 FY | 24.04 Million AUD | 23.2% |
| 2012 Q1 | 4.87 Million AUD | 0.0% |
| 2012 Q2 | 4.87 Million AUD | 0.0% |
| 2012 Q3 | 4.87 Million AUD | 0.0% |
| 2012 Q4 | 6.01 Million AUD | 23.2% |
| 2012 FY | 19.51 Million AUD | 24.17% |
| 2011 Q2 | 3.92 Million AUD | 0.0% |
| 2011 Q4 | 4.87 Million AUD | 24.17% |
| 2011 FY | 15.71 Million AUD | 27.45% |
| 2011 Q1 | 3.92 Million AUD | -0.0% |
| 2011 Q3 | 3.92 Million AUD | -0.0% |
| 2010 FY | 12.33 Million AUD | 20.15% |
| 2010 Q4 | 3.92 Million AUD | 27.45% |
| 2010 Q3 | 3.08 Million AUD | 0.0% |
| 2010 Q2 | 3.08 Million AUD | 0.0% |
| 2010 Q1 | 3.08 Million AUD | 0.0% |
| 2009 Q2 | 2.56 Million AUD | 0.0% |
| 2009 FY | 10.26 Million AUD | 19.57% |
| 2009 Q4 | 3.08 Million AUD | 20.15% |
| 2009 Q3 | 2.56 Million AUD | 0.0% |
| 2009 Q1 | 2.56 Million AUD | 0.0% |
| 2008 Q2 | 2.14 Million AUD | 0.0% |
| 2008 Q4 | 2.56 Million AUD | 19.85% |
| 2008 Q1 | 2.14 Million AUD | 0.0% |
| 2008 FY | 8.58 Million AUD | 26.04% |
| 2008 Q3 | 2.14 Million AUD | 0.0% |
| 2007 Q4 | 2.14 Million AUD | 25.74% |
| 2007 FY | 6.81 Million AUD | 0.0% |
| 2007 Q3 | 1.7 Million AUD | -0.0% |
| 2007 Q1 | 1.7 Million AUD | -0.0% |
| 2007 Q2 | 1.7 Million AUD | 0.0% |
| 2006 Q4 | 1.7 Million AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Althea Group Holdings Limited | 2.13 Million AUD | -1898.311% |
| Cann Group Limited | 3.19 Million AUD | -1233.459% |
| ECS Botanics Holdings Ltd | 7.51 Million AUD | -467.113% |
| Ecofibre Limited | -1.08 Million AUD | 4041.166% |
| Elixinol Wellness Limited | -1.8 Million AUD | 2461.641% |
| Hygrovest Limited | 260 Thousand AUD | -16286.154% |
| IDT Australia Limited | 6.7 Million AUD | -535.691% |
| Invion Limited | 1 Million AUD | -4146.645% |
| Little Green Pharma Ltd | 11.97 Million AUD | -255.697% |
| Live Verdure Ltd | 695.99 Thousand AUD | -6021.326% |
| Medical Developments International Limited | -2.5 Million AUD | 1804.16% |
| Vitura Health Limited | 34.21 Million AUD | -24.501% |